☰

Yung-Yi Cheng - Publications

Affiliations: 
2021-2021 Eshelman School of Pharmacy University of North Carolina, Chapel Hill, Chapel Hill, NC 
Tree Info Similar researchers PubMed Report error

24 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Wang M, Rousseau B, Qiu K, Huang G, Zhang Y, Su H, Le Bihan-Benjamin C, Khati I, Artz O, Foote MB, Cheng YY, Lee KH, Miao MZ, Sun Y, Bousquet PJ, et al. Killing tumor-associated bacteria with a liposomal antibiotic generates neoantigens that induce anti-tumor immune responses. Nature Biotechnology. PMID 37749267 DOI: 10.1038/s41587-023-01957-8  0.58
2022 Wang Y, Huang X, Zhang X, Wang J, Li K, Liu G, Lu K, Zhang X, Xie C, Zheng T, Cheng YY, Wang Q. Synthesis and Biological Evaluation of Novel Allobetulon/Allobetulin-Nucleoside Conjugates as AntitumorAgents. Molecules (Basel, Switzerland). 27. PMID 35897914 DOI: 10.3390/molecules27154738  0.355
2021 Li QR, Cheng YY, Zhao L, Huang XL, Jiang XG, Cui YD, Morris-Natschke SL, Goto M, Chen CH, Lee KH, Chen DF, Zhang J. New Phorbol Ester Derivatives as Potent Anti-HIV Agents. Bioorganic & Medicinal Chemistry Letters. 128319. PMID 34403728 DOI: 10.1016/j.bmcl.2021.128319  0.478
2020 Yin H, Zhang MJ, An RF, Zhou J, Liu W, Morris-Natschke SL, Cheng YY, Lee KH, Huang XF. Diosgenin Derivatives as Potential Antitumor Agents: Synthesis, Cytotoxicity, and Mechanism of Action. Journal of Natural Products. PMID 33381964 DOI: 10.1021/acs.jnatprod.0c00698  0.504
2020 Wang Q, Li Y, Zheng L, Huang X, Wang Y, Chen CH, Cheng YY, Morris-Natschke SL, Lee KH. Novel Betulinic Acid-Nucleoside Hybrids with Potent Anti-HIV Activity. Acs Medicinal Chemistry Letters. 11: 2290-2293. PMID 33214842 DOI: 10.1021/Acsmedchemlett.0C00414  0.467
2020 Zhang ZJ, Morris-Natschke SL, Cheng YY, Lee KH, Li RT. Development of anti-influenza agents from natural products. Medicinal Research Reviews. PMID 32677056 DOI: 10.1002/Med.21707  0.355
2020 Wu HF, Morris-Natschke SL, Xu XD, Yang MH, Cheng YY, Yu SS, Lee KH. Recent advances in natural anti-HIV triterpenoids and analogs. Medicinal Research Reviews. PMID 32666531 DOI: 10.1002/Med.21708  0.425
2020 Huang XL, Chen JL, Li XL, Zhao L, Cui YD, Liu JY, Morris-Natschke SL, Masuo G, Cheng YY, Lee KH, Chen DF, Zhang J. Synthesis and anticancer activities of biotinylated derivatives of glaucocalyxin A and oridonin. Journal of Asian Natural Products Research. 1-9. PMID 32441118 DOI: 10.1080/10286020.2020.1760851  0.43
2020 Liu Y, Qiu N, Shen L, Liu Q, Zhang J, Cheng YY, Lee KH, Huang L. Nanocarrier-mediated immunogenic chemotherapy for triple negative breast cancer. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 32360890 DOI: 10.1016/J.Jconrel.2020.04.040  0.521
2020 Huang HT, Zhang LJ, Huang HC, Hwang SY, Wu CL, Lin YC, Liaw CC, Cheng YY, Morris-Natschke SL, Huang CY, Lee KH, Kuo YH. Cucurbitane-Type Triterpenoids from the Vines of and Their Anti-inflammatory Activities. Journal of Natural Products. PMID 32357011 DOI: 10.1021/Acs.Jnatprod.9B00592  0.427
2020 Lu Y, Huang YS, Chen CH, Akiyama T, Morris-Natschke SL, Cheng YY, Chen IS, Yang SZ, Chen DF, Lee KH. Anti-HIV tigliane diterpenoids from Reutealis trisperma. Phytochemistry. 174: 112360. PMID 32229336 DOI: 10.1016/J.Phytochem.2020.112360  0.455
2019 Yang JH, Wang XY, Zhou YP, Lu R, Chen CH, Zhang MH, Cheng YY, Morris-Natschke SL, Lee KH, Wang YS. Carbazole Alkaloids from : Isolation, Characterization, and Anti-HIV Evaluation. Molecules (Basel, Switzerland). 25. PMID 31888067 DOI: 10.3390/molecules25010099  0.447
2019 Wang GK, Zhang N, Yao JN, Yu Y, Wang G, Hung CC, Cheng YY, Morris-Natschke SL, Zhou ZY, Liu JS, Lee KH. Kalshinoids A-F, Anti-inflammatory Sesquiterpenes from . Journal of Natural Products. PMID 31804830 DOI: 10.1021/Acs.Jnatprod.9B00693  0.417
2019 Chen Z, Huang KY, Ling Y, Goto M, Duan HQ, Tong XH, Liu YL, Cheng YY, Morris-Natschke SL, Yang PC, Yang SL, Lee KH. Discovery of an Oleanolic Acid/Hederagenin-Nitric Oxide Donor Hybrid as an EGFR Tyrosine Kinase Inhibitor for Non-Small-Cell Lung Cancer. Journal of Natural Products. PMID 31718182 DOI: 10.1021/Acs.Jnatprod.9B00659  0.472
2019 Liu Q, Cheng YY, Li W, Huang L, Asada Y, Hsieh MT, Morris-Natschke SL, Chen CH, Koike K, Lee KH. Synthesis and Structure-Activity Relationship Correlations of Gnidimacrin Derivatives as Potent HIV-1 Inhibitors and HIV Latency Reversing Agents. Journal of Medicinal Chemistry. PMID 31343875 DOI: 10.1021/Acs.Jmedchem.9B00339  0.449
2019 Wang GK, Jin WF, Zhang N, Wang G, Cheng YY, Morris-Natschke SL, Goto M, Zhou ZY, Liu JS, Lee KH. Kalshiolin A, new lignan from . Journal of Asian Natural Products Research. 1-7. PMID 31190564 DOI: 10.1080/10286020.2019.1592164  0.434
2019 Chen PY, Chang CC, Huang HC, Zhang LJ, Liaw CC, Lin YC, Nguyen NL, Vo TH, Cheng YY, Morris-Natschke SL, Lee KH, Kuo YH. New Dammarane-type Saponins from . Molecules (Basel, Switzerland). 24. PMID 30965662 DOI: 10.3390/molecules24071375  0.461
2018 Chang YT, Wang CCN, Wang JY, Lee TE, Cheng YY, Morris-Natschke SL, Lee KH, Hung CC. Tenulin and isotenulin inhibit P-glycoprotein function and overcome multidrug resistance in cancer cells. Phytomedicine : International Journal of Phytotherapy and Phytopharmacology. 53: 252-262. PMID 30668405 DOI: 10.1016/J.Phymed.2018.09.008  0.352
2015 Liu CY, Cheng YY, Chang LC, Huang LJ, Chou LC, Huang CH, Tsai MT, Liao CC, Hsu MH, Lin HY, Wu TS, Wen YF, Zhao Y, Kuo SC, Lee KH. Design and synthesis of new 2-arylnaphthyridin-4-ones as potent antitumor agents targeting tumorigenic cell lines. European Journal of Medicinal Chemistry. 90: 775-87. PMID 25528332 DOI: 10.1016/j.ejmech.2014.11.062  0.463
2013 Cheng YY, Liu CY, Tsai MT, Lin HY, Yang JS, Wu TS, Kuo SC, Huang LJ, Lee KH. Design, synthesis, and mechanism of action of 2-(3-hydroxy-5-methoxyphenyl)-6-pyrrolidinylquinolin-4-one as a potent anticancer lead. Bioorganic & Medicinal Chemistry Letters. 23: 5223-7. PMID 23916255 DOI: 10.1016/j.bmcl.2013.06.083  0.477
2013 Cheng YY, Liu CY, Huang LJ, Huang CH, Lee KH, Lin CT, Kuo SC. Mechanistic studies on regioselective dephosphorylation of phosphate prodrugs during a facile synthesis of antitumor phosphorylated 2-phenyl-6,7-methylenedioxy-1H-quinolin-4-one. Molecules (Basel, Switzerland). 18: 8028-45. PMID 23884134 DOI: 10.3390/molecules18078028  0.357
2013 Huang SM, Cheng YY, Chen MH, Huang CH, Huang LJ, Hsu MH, Kuo SC, Lee KH. Design and synthesis of 2-(3-alkylaminophenyl)-6-(pyrrolidin-1-yl)quinolin-4-ones as potent antitumor agents. Bioorganic & Medicinal Chemistry Letters. 23: 699-701. PMID 23260351 DOI: 10.1016/j.bmcl.2012.11.105  0.494
2012 Cheng YY, Yang JS, Tsai SC, Liaw CC, Chung JG, Huang LJ, Lee KH, Lu CC, Chien HC, Tsuzuki M, Kuo SC. The newly synthesized 2-(3-hydroxy-5-methoxyphenyl)-6,7-methylenedioxyquinolin-4-one triggers cell apoptosis through induction of oxidative stress and upregulation of the p38 MAPK signaling pathway in HL-60 human leukemia cells. Oncology Reports. 28: 1482-90. PMID 22825350 DOI: 10.3892/or.2012.1923  0.357
2011 Chen CT, Hsu MH, Cheng YY, Liu CY, Chou LC, Huang LJ, Wu TS, Yang X, Lee KH, Kuo SC. Synthesis and in vitro anticancer activity of 6,7-methylenedioxy (or 5-hydroxy-6-methoxy)-2-(substituted selenophenyl)quinolin-4-one analogs. European Journal of Medicinal Chemistry. 46: 6046-56. PMID 22030314 DOI: 10.1016/j.ejmech.2011.10.017  0.483
Show low-probability matches.